Immune-Mediated Inflammatory Diseases Diagnosed In Internal Medicine Department at the University Hospital Center of the Point G: An Epidemiological and Clinical Overview
Trends in Internal Medicine · 2022
DOI: 10.33425/2771-5906.1012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Internal Medicine, 2022. Verfasst von Keita Kaly und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Immune-mediated inflammatory diseases (IMIDs) characterized by three nosological entities, autoimmune diseases, auto inflammatory diseases and inflammatory diseases of undetermined mechanism, share in common the inflammatory process but their clinical and biological expressions are extremely diverse. A panoramic study of IMIDs could contribute to identify the epidemiological, immuno-genetical, environmental, pathophysiological and clinical disparities. We aimed in this work to describe epidemiological and clinical aspects of all IMIDs diagnosed in internal medicine department.
Methods
We retrospectively analyzed data from patients hospitalized for IMIDs between 2018 and 2019.
Results
921 patients hospitalized from 2018 to 2019, 205 patients (56.10% female) presented with immune-mediated inflammatory disease, of which two cases of associations, which is 207 cases of IMIDs (22.48%). IMIDs were dominated by inflammatory diseases of undetermined mechanism (113 cases) followed by autoimmune diseases (84 cases) and auto inflammatory diseases (10 cases). Organ-specific autoimmune diseases (72 cases) dominated the autoimmune diseases: type 1 diabetes (40 cases), Graves' disease (13 cases) versus systemic autoimmune diseases (12 cases): rheumatoid arthritis (04 cases), systemic lupus erythematosus (03 cases). There were no cases of monogenic forms. “organ-specific” polygenic forms (07 cases) dominated the polygenic auto-inflammatory diseases: gout (02 cases), ulcerative colitis (02 cases) versus "systemic" polygenic forms (03 cases): Horton's disease (01 case). Inflammatory diseases of undetermined mechanism were dominated by neoplasia (109 cases): Solid tumor (77 cases) [hepatocellular carcinoma (14 cases), breast cancer (09 cases)] and hematological malignancies (31 cases) [non-Hodgkin's malignant lymphoma (14 cases), chronic myeloid leukemia (8 cases)] followed by paraneoplastic syndromes (02 cases) and inflammatory diseases of iatrogenic origin (02 cases).
Conclusion
IMIDs is frequently diagnosed in internal medicine and dominated by inflammatory diseases of undetermined mechanism followed by autoimmune diseases and auto inflammatory diseases.
Zitieren
APA
Kaly, K., Djenebou, T., Djibril, S., Mamadou, C., Mamadou, M., Amado, D. I., Hamar, T. A., Sylla, D., Doumbia, N., Abdramane, T., Abass, S., Maimouna, T., Karim, D. A., Mahamadou, D., Mamadou, W., Kaya, S. A., Sidibe, T. A., Aly, D. D., Kader, T. A., & Alassane, T. H. (2022). Immune-Mediated Inflammatory Diseases Diagnosed In Internal Medicine Department at the University Hospital Center of the Point G: An Epidemiological and Clinical Overview. Trends in Internal Medicine. https://doi.org/10.33425/2771-5906.1012
Vancouver
Kaly K, Djenebou T, Djibril S, Mamadou C, Mamadou M, Amado DI, et al. Immune-Mediated Inflammatory Diseases Diagnosed In Internal Medicine Department at the University Hospital Center of the Point G: An Epidemiological and Clinical Overview. Trends in Internal Medicine. 2022. doi:10.33425/2771-5906.1012
BibTeX
@article{Kaly2022,
author = {Kaly, Keita and Djenebou, Traore and Djibril, Sy and Mamadou, Cissoko and Mamadou, Malle and Amado, Dembele Ibrahim and Hamar, Traore Aminata and Sylla, Djeneba and Doumbia, Nanko and Abdramane, Traore and Abass, Sanogo and Maimouna, Togo and Karim, Dembele Abdoul and Mahamadou, Diakite and Mamadou, Wele and Kaya, Soukho Assetou and Sidibe, Traore Assa and Aly, Diallo Dapa and Kader, Traore Abde and Alassane, Traore Hamar},
title = {Immune-Mediated Inflammatory Diseases Diagnosed In Internal Medicine Department at the University Hospital Center of the Point G: An Epidemiological and Clinical Overview},
journal = {Trends in Internal Medicine},
year = {2022},
doi = {10.33425/2771-5906.1012}
}
EUVIMED